Operating income decreased 34.3%
Operating income changed -34.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -34.3% from the comparable as-filed period.
Operating margin changed -2265865 basis points from the comparable as-filed period.
Revenue changed -90.2% from the comparable as-filed period.
Research & development changed +117.3% from the comparable as-filed period.
Gross profit changed -90.3% from the comparable as-filed period.
Inventory changed +636.3% from the comparable as-filed period.
Trade receivables changed +105.1% from the comparable as-filed period.
Shares outstanding changed -91.5% from the comparable as-filed period.
Cost of revenue changed -90.1% from the comparable as-filed period.
Current assets changed -51.9% from the comparable as-filed period.
Current liabilities changed +86.7% from the comparable as-filed period.
Total assets changed -30.2% from the comparable as-filed period.
Inventory / revenue changed +2123949 basis points from the comparable as-filed period.
Current ratio changed -74.3% from the comparable as-filed period.
R&D / revenue changed +304092 basis points from the comparable as-filed period.
Receivables / revenue changed +25108 basis points from the comparable as-filed period.
Working capital / assets changed -13045 basis points from the comparable as-filed period.
Gross margin changed -56 basis points from the comparable as-filed period.
Working capital changed -2187.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.